Preventing VTE in Outpatients With Cancer

Chest. 2012 Jul;142(1):265-266. doi: 10.1378/chest.12-0423.

Authors

Alok A Khorana¹, Alex C Spyropoulos², Jeffrey Zwicker³, Gary H Lyman⁴, Charles W Francis²

Affiliations

¹ James P. Wilmot Cancer Center and Department of Medicine, University of Rochester, Rochester, NY. Electronic address: [email protected].
² James P. Wilmot Cancer Center and Department of Medicine, University of Rochester, Rochester, NY.
³ Division of Hemostasis-Thrombosis, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.
⁴ Duke University and Duke Cancer Institute, Durham, NC.

No abstract available

Publication types

Letter
Research Support, N.I.H., Extramural
Comment

MeSH terms

Evidence-Based Medicine*
Fibrinolytic Agents / adverse effects*
Fibrinolytic Agents / therapeutic use*
Humans
Societies, Medical*
Venous Thromboembolism / drug therapy*
Venous Thromboembolism / prevention & control*

Substances

Fibrinolytic Agents

Grants and funding